Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Keir et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(22)00261-2
https://c19early.org/keir.html